EUVIMEDEUVIMED entdecken
Crossref

Data on 3 New GLP-1 Drugs for Weight Loss That May Be Approved This Year

Rita Rubin

JAMA · 24.02.2026 · 335 (8) · 653

DOI: 10.1001/jama.2026.0287 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, erschienen am 24.02.2026. Verfasst von Rita Rubin. Beteiligte Einrichtung: Lead Senior Staff Writer, Medical News, JAMA. Die Arbeit wurde bisher 7-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This Medical News article discusses clinical trial data for weight-loss medications, in both injectable and pill formations, that are currently under review with US Food and Drug Administration.

Autor:innen und Institutionen

  • Lead Senior Staff Writer, Medical News, JAMA.

Zitieren

APA

Rubin, R. (2026). Data on 3 New GLP-1 Drugs for Weight Loss That May Be Approved This Year. JAMA, 335(8), 653. https://doi.org/10.1001/jama.2026.0287

Vancouver

Rubin R. Data on 3 New GLP-1 Drugs for Weight Loss That May Be Approved This Year. JAMA. 2026;335(8):653. doi:10.1001/jama.2026.0287

BibTeX
@article{Rubin2026,
  author = {Rubin, Rita},
  title = {Data on 3 New GLP-1 Drugs for Weight Loss That May Be Approved This Year},
  journal = {JAMA},
  year = {2026},
  volume = {335},
  number = {8},
  pages = {653},
  doi = {10.1001/jama.2026.0287}
}
Kostenlos starten →